Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alicaforsen in Active Crohn's Disease
NCT00048295Phase 3Completed
- Sponsor
- Ionis Pharmaceuticals
- Start
- May 2002
- Modality
- Small Interfering RNA (siRNA), Modified DNA Oligonucleotides, Single-strand DNA
- Countries
- 6
01
Overview
A Phase 3 trial of alicaforsen in Crohn's disease, sponsored by Ionis Pharmaceuticals. Started May 2002; status: completed.
02
Drugs
alicaforsen
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00048295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00048295.